Angel T. Alvarado, A. M. Muñoz, Jessica Michiko Miyasato, E. Alvarado, Berta Loja, L. Villanueva, Mario Pineda, M. Bendezu, Juan J. Palomino-Jhong, Jorge A. García
{"title":"秘鲁两种多源(通用)苯妥英钠(100毫克)制剂的体外治疗等效性","authors":"Angel T. Alvarado, A. M. Muñoz, Jessica Michiko Miyasato, E. Alvarado, Berta Loja, L. Villanueva, Mario Pineda, M. Bendezu, Juan J. Palomino-Jhong, Jorge A. García","doi":"10.14227/dt270420p33","DOIUrl":null,"url":null,"abstract":"( 13 ). An f 2 value of exactly 100 means that the profile of the generic drug is identical to the reference; if the value is 50–99, then the profiles are similar ( 10, 12, ABSTRACT This in vitro study evaluated the therapeutic equivalence of two multisource (generic) formulations of 100-mg phenytoin as immediate-release tablets available in the Peruvian pharmaceutical market, compared with the reference medicine, to establish interchangeability. The mean weight, hardness, and content of active substance were evaluated, prior to analyzing the dissolution profile. USP dissolution apparatus 2 (paddle) was used at 75 rpm with 900 mL of dissolution medium at 37 ± 0.5 °C at pH levels of 1.2, 4.5, and 6.8. The generic and reference formulations had similar weight or drug content, but hardness values were significantly different ( p = 0.029). At pH 1.2, the generic products were considered therapeutically equivalent to the reference product based on similarity factor ( f 2 ) and dissolution efficiency values; however, at pH 4.5 and 6.8, there were differences in dissolution performance based on f 2 values below the acceptable range.","PeriodicalId":11380,"journal":{"name":"Dissolution Technologies","volume":"1 1","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":"{\"title\":\"In Vitro Therapeutic Equivalence of Two Multisource (Generic) Formulations of Sodium Phenytoin (100 mg) Available in Peru\",\"authors\":\"Angel T. Alvarado, A. M. Muñoz, Jessica Michiko Miyasato, E. Alvarado, Berta Loja, L. Villanueva, Mario Pineda, M. Bendezu, Juan J. Palomino-Jhong, Jorge A. García\",\"doi\":\"10.14227/dt270420p33\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"( 13 ). An f 2 value of exactly 100 means that the profile of the generic drug is identical to the reference; if the value is 50–99, then the profiles are similar ( 10, 12, ABSTRACT This in vitro study evaluated the therapeutic equivalence of two multisource (generic) formulations of 100-mg phenytoin as immediate-release tablets available in the Peruvian pharmaceutical market, compared with the reference medicine, to establish interchangeability. The mean weight, hardness, and content of active substance were evaluated, prior to analyzing the dissolution profile. USP dissolution apparatus 2 (paddle) was used at 75 rpm with 900 mL of dissolution medium at 37 ± 0.5 °C at pH levels of 1.2, 4.5, and 6.8. The generic and reference formulations had similar weight or drug content, but hardness values were significantly different ( p = 0.029). At pH 1.2, the generic products were considered therapeutically equivalent to the reference product based on similarity factor ( f 2 ) and dissolution efficiency values; however, at pH 4.5 and 6.8, there were differences in dissolution performance based on f 2 values below the acceptable range.\",\"PeriodicalId\":11380,\"journal\":{\"name\":\"Dissolution Technologies\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dissolution Technologies\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.14227/dt270420p33\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dissolution Technologies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14227/dt270420p33","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
In Vitro Therapeutic Equivalence of Two Multisource (Generic) Formulations of Sodium Phenytoin (100 mg) Available in Peru
( 13 ). An f 2 value of exactly 100 means that the profile of the generic drug is identical to the reference; if the value is 50–99, then the profiles are similar ( 10, 12, ABSTRACT This in vitro study evaluated the therapeutic equivalence of two multisource (generic) formulations of 100-mg phenytoin as immediate-release tablets available in the Peruvian pharmaceutical market, compared with the reference medicine, to establish interchangeability. The mean weight, hardness, and content of active substance were evaluated, prior to analyzing the dissolution profile. USP dissolution apparatus 2 (paddle) was used at 75 rpm with 900 mL of dissolution medium at 37 ± 0.5 °C at pH levels of 1.2, 4.5, and 6.8. The generic and reference formulations had similar weight or drug content, but hardness values were significantly different ( p = 0.029). At pH 1.2, the generic products were considered therapeutically equivalent to the reference product based on similarity factor ( f 2 ) and dissolution efficiency values; however, at pH 4.5 and 6.8, there were differences in dissolution performance based on f 2 values below the acceptable range.
期刊介绍:
Dissolution Technologies is a peer reviewed quarterly
publication reporting ongoing, useful information on
dissolution testing of pharmaceuticals. It provides an
international forum for dissolution analysts to receive
and exchange information on various dissolution topics.
Dissolution Technologies welcomes submissions related
to dissolution, in vitro release, and disintegration testing.
These topics should be the major focus of the article.
Do not submit articles where the focus is formulation
development with dissolution testing as one of many
tests.